KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash & Current Investments (2016 - 2025)

Bausch Health Companies' Cash & Current Investments history spans 17 years, with the latest figure at $16.0 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 98.67% year-over-year to $16.0 million; the TTM value through Sep 2025 reached $1.3 billion, up 86.37%, while the annual FY2025 figure was $16.0 million, 98.67% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $16.0 million at Bausch Health Companies, down from $1.3 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $1.9 billion in Q3 2021 and bottomed at $16.0 million in Q4 2025.
  • The 5-year median for Cash & Current Investments is $757.5 million (2023), against an average of $980.5 million.
  • The largest YoY upside for Cash & Current Investments was 177.21% in 2025 against a maximum downside of 98.67% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $582.0 million in 2021, then grew by 1.55% to $591.0 million in 2022, then surged by 62.77% to $962.0 million in 2023, then rose by 24.84% to $1.2 billion in 2024, then plummeted by 98.67% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Cash & Current Investments are $16.0 million (Q4 2025), $1.3 billion (Q3 2025), and $1.7 billion (Q2 2025).